ARTICLE | Company News
Antisoma licenses Theranase from NIH
September 10, 2001 7:00 AM UTC
Antisoma (LSE:ASM; NASD-EU:ASOM) received exclusive worldwide rights from NIH to use Theranase recombinant cytotoxic RNase in combination with monoclonal antibodies against PEM ( polymorphic epithelia...